Company / Financials
Pasithea Therapeutics Corp. Financials
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$15.1K
FY2022 · 0.0% YoY
Net Income
-$2.2M
FY2022 · -5203.3% YoY
Profit Margin
-14430.5%
FY2022 · net income / revenue
ROE
-4.2%
FY2022 · return on equity
Total Assets
$45.2M
FY2022
Total Debt
-
FY2022
Equity
$51.4M
FY2022
ROA
-4.8%
FY2022 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$15.1K0.0% YoYNet Income HistoryProfit after all expenses and taxes-$2.2M-5203.3% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold$17.3K0.0% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$4.5M-10898.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$4.5M+10892.6% YoYR&D Expense HistoryResearch and development spending$2.7MInterest Expense HistoryCost of borrowing and debt obligations$508+200.0% YoYEPS (Basic) HistoryBasic earnings per share-$0.21EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.21